3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
9
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, T-Cell
6
Lymphoma
6
Sezary Syndrome
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Malignant mesenchymal tumor
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
63
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
24
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
durvalumab
11
Nivolumab
11
rucaparib
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
romidepsin
×
Clear all
No trials found.